AUG 09, 2020 10:20 AM PDT

Reducing post-surgery metastasis in colorectal cancer patients

Scientists have recently shown the successful reduction of metastasis in post-surgery colorectal cancer patients. The study, reported in Cancer earlier this summer, concludes a three-year period during which researchers followed 34 patients receiving treatment for colorectal cancer.

The Tel Aviv University scientists leading the study administered medication to the patients during the pre- and post-surgical period in order to monitor corporal stress responses and physiological inflammation. The drugs administered were Propranolol (Deralin), an anti-anxiety and blood pressure reducing dru, and Etodolac (Etopan), an anti-inflammatory analgesic. The patients received them starting five days before surgery throughout the two weeks following the surgery. Half of the patients were administered a placebo treatment as a control group.

Reducing stress and inflammation aided in impeding the development of metastases, say the researchers. "When the body is in a state of stress, whether physiological (from surgery) or psychological, this causes a release of high amounts of two types of hormones, prostaglandins and catecholamines," explains Professor Shamgar Ben-Eliyahu from TAU's School of Psychological Sciences and Sagol School of Neuroscience.

"These hormones suppress the activity of the immune cells, indirectly promoting the development of cancer metastases. In addition, these hormones also directly promote the acquisition of metastatic traits in cancer tissue. Our study shows that inexpensive, accessible medication treatment could be used in order to reduce body stress responses and inflammation associated with surgery, which affects the tumor, significantly reducing the risk of metastases that might be detected months or years after surgery."

Photo: Pixabay

Together with Professor Oded Zmora from Shamir (Assaf Harofeh) Medical Center, Professor Ben-Eliyahu found that 12.5% (2 out of 16) of patients administered the drug treatment showed metastasis, compared to 33% (6 out of 18 patients) in the control group. While the findings suggest significant improvement, the researchers say that in order to confirm their findings further tests with larger populations should be established.

The team analyzed cancerous tissues from the patients to determine how the medications reduced metastasis. They found that the medications positively affect in the number and type of infiltrating tumor leukocytes, creating a microenvironment that is hostile to cancer cells’ growth.

Sources: Cancer, Eureka Alert

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
MAY 15, 2021
Cancer
What does your polygenic risk score mean?
MAY 15, 2021
What does your polygenic risk score mean?
A study published in The American Journal of Clinical Nutrition recommends that people with a high polygenic risk score ...
MAY 29, 2021
Cancer
New device detects skin cancer from tensile stiffness
MAY 29, 2021
New device detects skin cancer from tensile stiffness
A research team composed of scientists from City University of Hong Kong (CityU) has designed an automated non-invasive ...
JUN 10, 2021
Cell & Molecular Biology
Does Lithium Prevent Colon Cancer?
JUN 10, 2021
Does Lithium Prevent Colon Cancer?
Researchers found that a drug used in the treatment of mental illness can promote the fitness of healthy gut stem cells, ...
JUN 14, 2021
Cell & Molecular Biology
Can An Omega-3 Fatty Acid Destroy Tumors?
JUN 14, 2021
Can An Omega-3 Fatty Acid Destroy Tumors?
The body needs fatty acts for a variety of functions, and the health benefits of taking fatty acid supplements have long ...
JUN 26, 2021
Cancer
Immunotherapy Drug Shows Promise for Obese Patients with Breast Cancer
JUN 26, 2021
Immunotherapy Drug Shows Promise for Obese Patients with Breast Cancer
Research shows that obese patients with cancers including ovarian and melanoma may respond better to a certain kind of i ...
JUL 07, 2021
Cancer
Chemotherapy Disrupts Gut Bacteria in Cancer Patients
JUL 07, 2021
Chemotherapy Disrupts Gut Bacteria in Cancer Patients
Researchers from Australia have found that the conventional chemotherapy used to treat various cancers disrupts the comp ...
Loading Comments...